Brian M. Sullivan

Arcturus Therapeutics (United States) — United States

Medicine · Health Sciences

25h-index3.0kcitations51works18.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infections and Outbreaks Research(22), Viral Infections and Vectors(14), SARS-CoV-2 and COVID-19 Research(12), Immunotherapy and Immune Responses(8), Hepatitis B Virus Studies(6)

Publications51 total

Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials.
PubMed·2026
Sustained Humoral Activation through self-amplifying mRNA Vaccination Enhances Longitudinal Antibody Function in a Phase III Trial
bioRxiv (Cold Spring Harbor Laboratory)·2025Open Access
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials
Nature Communications·2024· 67 citedOpen Access
Persistent CD8+ T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markers
Frontiers in Immunology·2024· 6 citedOpen Access
Safety and immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine
Research Square (Research Square)·2023· 3 citedOpen Access
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
npj Vaccines·2022· 58 citedOpen Access
Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors
PLoS neglected tropical diseases·2022· 14 citedOpen Access
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
npj Vaccines·2022· 14 citedOpen Access
Inflammatory platelet production stimulated by tyrosyl-tRNA synthetase mimicking viral infection
Proceedings of the National Academy of Sciences·2022· 34 citedOpen Access
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus
Science Translational Medicine·2022· 31 citedOpen Access
Microbial Metabolite 3-Indolepropionic Acid Mediates Immunosuppression
Metabolites·2022· 19 citedOpen Access
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
2022Open Access
Vaccination of non-human primates with self-amplifying mRNA vaccines reveal two distinct immunotypes across major SARS-CoV-2 variants.
The Journal of Immunology·2022
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
Molecular Therapy·2021· 174 citedOpen Access
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
Emerging infectious diseases·2020· 25 citedOpen Access
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
Nature Communications·2020· 167 citedOpen Access
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
2020· 14 citedOpen Access
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae
The Journal of Infectious Diseases·2020· 20 citedOpen Access
Reevaluating HLA-A2-restricted Lassa epitopes in human Lassa fever survivors
The Journal of Immunology·2020
Identification of Common CD8<sup>+</sup>T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
Journal of Virology·2020· 25 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Michael B. A. Oldstone(23), Robert F. Garry(14), Juan Carlos de la Torre(13), Donald S. Grant(12), Mambu Momoh(10), John Demby Sandi(9), Luis M. Branco(8), John S. Schieffelin(8), Megan J. Welch(7), Saori Sakabe(7), Augustine Goba(7), John R. Teijaro(6), Pardis C. Sabeti(6), Rose E. Sekulovich(6), Jessica N. Hartnett(6), Brian C. Ware(6), Lansana Kanneh(6), Pad Chivukula(5), Christian Happi(5), Kelly Lindert(5)